There is no product in the shopping cart, buy it!
| Description | GlycoFlux™ AAV1-PRKAA2 Viral Particle establishes persistent PRKAA2 (AMPK α2) expression to inactivate ACC and HMG-CoA reductase during metabolic stress and support myocardial energy homeostasis and insulin sensitivity, and this product preferentially targets liver, central nervous system, and smooth muscle to sustain extended lipid-flux and metabolic-checkpoint studies for research use only. |
| Product Type | Recombinant AAV1 |
| Target | PRKAA2 |
| Species | Human |
| Promotor | CMV, CAG, TRE, or other promoters |
| Tissue Tropism | Smooth muscle, Central Nervous System (CNS), Retina, Pancreas, Inner Ear, Heart, Liver |
| Packaging System | AAV Triple-Plasmid Transfection System |
| Packaging Cell | HEK293T |
| Application | This AAV1 viral particle is primarily used for overexpressing target genes in muscle tissues (smooth muscle, heart) and the central nervous system (CNS) / sensory organs (retina, inner ear). It is an ideal tool for research and pre-clinical studies focused on myopathies, cardiac disorders, and certain neurological or sensory genetic diseases. |
| Shipping | Shipped on dry ice, with temperature maintained at ≤ -80°C. |
| Storage | Store at -80°C to preserve viral titer and stability. |
| Handling Notes | Store this product at -80°C and minimize freeze-thaw cycles to preserve viral titer. For safety, handle in a certified biological safety cabinet and wear appropriate PPE (lab coat, gloves, and eye protection). |
| Product Disclaimer | This product is intended for research use only and is not approved for diagnostic procedures or clinical applications. Users are solely responsible for implementing appropriate safety practices and complying with all applicable laws, regulations, and institutional policies. While Creative Biolabs is committed to rigorous quality control, no guarantee is made regarding performance in any particular assay or application. |
| Titer Assay | qPCR/TCID50 |
| Mycoplasma Test | No mycoplasma contamination was detected. |
| Sterility | Sterility testing verified the absence of microbial contamination. |
| Transduction Evaluation | Upon request, Creative Biolabs performs in vitro or in vivo transduction assays to assess AAV delivery to target cells and to quantify transgene expression and function. |
| Insert Identity Confirmation | All AAV preparations from Creative Biolabs are verified for vector-genome identity by PCR. In this assay, target cells are transduced with serial dilutions of the AAV preparation, harvested after a short incubation, and genomic DNA is isolated; a defined region of the packaged transgene is then PCR-amplified to confirm the expected sequence. |
| Full Name | Protein Kinase Amp-Activated Catalytic Subunit Alpha 2 |
| Alternative Name | AMPK; AMPK2; PRKAA; AMPKa2 |
| Location | 1p32.2 |
| Gene ID | 5563 |
| Summary | The protein encoded by this gene is a catalytic subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. Studies of the mouse counterpart suggest that this catalytic subunit may control whole-body insulin sensitivity and is necessary for maintaining myocardial energy homeostasis during ischemia. |